LINC00563

Across TCGA pan-cancer cohorts, LINC00563 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC00563’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC00563 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00563 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and KIRC are the cancer types where LINC00563 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00563 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	III,IV	−0.212	<.001	9	view →
LUSC	Female	All	−0.205	<.001	8	view →
KIRC	All	All	+0.035	<.001	7	view →
STAD	All	All	+0.097	.015	5	view →
BRCA	All	All	+0.054	.020	4	view →
BLCA	Female	III,IV	+0.052	.006	4	view →
PAAD	Male	All	−0.175	.022	2	view →
PRAD	All	All	+0.054	.005	2	view →
KICH	All	All	−0.042	.014	2	view →
THCA	All	IV	+0.045	.034	1	view →
KIRP	Female	All	+0.042	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC00563–LUAD

Open the LUAD breakdown →